CDKN1B is regulated by p53 (Abraham et al. 2005), an important tumor suppressor regulating cell cycle and the guardian of the genome (Weinberg 2007) that is underexpressed in aA:bb (DLC1:CDK6) patients. Here, TP53 is linked to neoplasm.